SEZ6L2 Antibody–Associated Cerebellar Ataxia Responsive to Sequential Immunotherapy

OBJECTIVES: Seizure-related 6 homolog like 2 (SEZ6L2) antibody–associated ataxia is an extremely rare disease. Six patients have been reported and none of them improved significantly with immunotherapy. Herein, we present the case of a patient with cerebellar ataxia and SEZ6L2 antibodies who benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehdiyeva, Ayla, Hietaharju, Aki, Sipilä, Jussi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Clinical/Scientific Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759717/
https://www.ncbi.nlm.nih.gov/pubmed/35031588
http://dx.doi.org/10.1212/NXI.0000000000001131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759717/
https://www.ncbi.nlm.nih.gov/pubmed/35031588
http://dx.doi.org/10.1212/NXI.0000000000001131

Ejemplares similares